X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2839) 2839
nanocapsules - chemistry (1815) 1815
animals (1642) 1642
nanoparticles (1604) 1604
humans (1421) 1421
nanoscience & nanotechnology (1063) 1063
pharmacology & pharmacy (1047) 1047
nanocapsules (1026) 1026
nanocapsules - administration & dosage (992) 992
particle size (879) 879
drug delivery systems (868) 868
mice (839) 839
nanocapsules - ultrastructure (825) 825
materials science, biomaterials (697) 697
drug-delivery (689) 689
drugs (640) 640
cancer (637) 637
cell line, tumor (618) 618
chemistry, multidisciplinary (570) 570
diffusion (535) 535
in-vitro (535) 535
male (508) 508
treatment outcome (508) 508
delivery (469) 469
materials science, multidisciplinary (448) 448
rats (448) 448
female (446) 446
vehicles (439) 439
nanostructure (419) 419
cell survival - drug effects (415) 415
engineering, biomedical (412) 412
analysis (387) 387
nanotechnology (373) 373
drug delivery (371) 371
antineoplastic agents - administration & dosage (368) 368
in-vivo (327) 327
liposomes (321) 321
materials testing (305) 305
release (304) 304
cells (299) 299
drug carriers - chemistry (285) 285
therapy (271) 271
chemistry, physical (270) 270
physics, applied (267) 267
encapsulation (263) 263
medicine (262) 262
polymers - chemistry (260) 260
chitosan (247) 247
tumors (243) 243
polymers (242) 242
polyethylene glycols - chemistry (238) 238
delayed-action preparations - administration & dosage (237) 237
original research (232) 232
antineoplastic agents - chemistry (230) 230
lipids - chemistry (225) 225
doxorubicin (218) 218
doxorubicin - administration & dosage (217) 217
international journal of nanomedicine (217) 217
chemotherapy (214) 214
micelles (213) 213
mice, inbred balb c (211) 211
cytotoxicity (210) 210
delayed-action preparations - chemistry (208) 208
poly (208) 208
research (204) 204
dentistry (203) 203
advanced basic science (199) 199
article (197) 197
nanoparticles - chemistry (193) 193
tissue distribution (192) 192
lipids (190) 190
stability (190) 190
nanomedicine (189) 189
mice, nude (188) 188
microspheres (183) 183
chitosan - chemistry (182) 182
surface properties (182) 182
health aspects (181) 181
nanospheres (181) 181
formulation (180) 180
hydrogen-ion concentration (179) 179
proteins (177) 177
biocompatibility (176) 176
carriers (176) 176
apoptosis (174) 174
nanopartikel (174) 174
solubility (173) 173
toxicity (173) 173
neoplasms, experimental - pathology (172) 172
administration, oral (171) 171
physics, condensed matter (170) 170
drug stability (168) 168
nanocarriers (168) 168
medicine, research & experimental (167) 167
drug compounding - methods (161) 161
gene delivery (161) 161
neoplasms, experimental - drug therapy (161) 161
paclitaxel (161) 161
care and treatment (160) 160
usage (158) 158
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3241) 3241
French (9) 9
Portuguese (6) 6
Chinese (4) 4
Japanese (4) 4
Russian (2) 2
Persian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2015, Volume 112, Issue 2, pp. E156 - E165
Current treatments to control pathological or unwanted immune responses often use broadly immunosuppressive drugs. New approaches to induce antigen-specific... 
Nanoparticles | Rapamycin | Anti-drug antibodies | Immune tolerance | Immunotherapy | THERAPEUTICS | anti-drug antibodies | IMMUNITY | TOLEROGENIC DENDRITIC CELLS | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | FACTOR-VIII | MECHANISMS | RESPONSES | immune tolerance | IMMUNOGENICITY | nanoparticles | UNRESPONSIVENESS | immunotherapy | rapamycin | Factor VIII - immunology | Oligodeoxyribonucleotides - administration & dosage | Nanoparticles - chemistry | Ovalbumin - immunology | Immunosuppression - methods | Nanocapsules - administration & dosage | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Hypersensitivity, Delayed - immunology | Nanocapsules - chemistry | Peptides - administration & dosage | Antigens - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Immunity, Humoral | Peptide Fragments - immunology | Proteins - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Disease Models, Animal | Lactic Acid - chemistry | Peptides - chemistry | Hemophilia A - immunology | Peptide Fragments - administration & dosage | Peptides - immunology | Immune Tolerance | Hemophilia A - therapy | Hypersensitivity, Delayed - therapy | Antigens - chemistry | Proteins - immunology | Encephalomyelitis, Autoimmune, Experimental - therapy | Sirolimus - administration & dosage | Animals | Ovalbumin - administration & dosage | Recombinant Proteins - immunology | Polyglycolic Acid - chemistry | Encephalomyelitis, Autoimmune, Experimental - prevention & control | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Hemocyanins - administration & dosage | Proteins - chemistry | Antigens | Usage | Research | Health aspects | Immunological tolerance | Immunological research | Immunology | Polymers | Chemical synthesis | Immune system | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
Journal Article
ACS Applied Materials and Interfaces, ISSN 1944-8244, 05/2015, Volume 7, Issue 17, pp. 9078 - 9087
Journal Article
Dalton Transactions, ISSN 1477-9226, 11/2014, Volume 43, Issue 42, pp. 15841 - 15850
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 38, pp. 22 - 35
Abstract Nanodiamond application in biotechnological and medical fields is nowadays in continuous progress. In fact, biocompatibility, reduced dimensions and... 
Advanced Basic Science | Dentistry | Antineoplastic properties | Nanodiamonds | Ciproten (5,7-dimethoxycoumarin) | Quercetin (3,3′,4′,5,6-pentahydroxyflavone) | Therapeutic approach | Natural bioactive compounds | Quercetin (3,3',4',5,6-pentahydroxyflavone) | MATERIALS SCIENCE, BIOMATERIALS | METASTASIS | INDUCED APOPTOSIS | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | CELL-CYCLE ARREST | ANTIOXIDANT PROPERTIES | BREAST-CANCER | Quercetin (3,3 ',4 ',5,6-pentahydroxyflavone) | QUERCETIN | BIOMEDICAL APPLICATIONS | DETONATION NANODIAMOND | DIAMOND NANOPARTICLES | Plant Extracts - chemistry | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanocomposites - chemistry | Apoptosis - drug effects | Nanocapsules - administration & dosage | Humans | Drug Carriers - administration & dosage | Coumarins - chemistry | Nanocapsules - chemistry | Nanocapsules - ultrastructure | Neoplasms, Experimental - pathology | Plant Extracts - administration & dosage | Surface Properties | Quercetin - administration & dosage | Nanocomposites - ultrastructure | Diffusion | Cell Survival - drug effects | Nanodiamonds - ultrastructure | Quercetin - chemistry | Nanodiamonds - administration & dosage | Nanodiamonds - chemistry | Coumarins - administration & dosage | Materials Testing | Treatment Outcome | Particle Size | Animals | Mice | HeLa Cells | Neoplasms, Experimental - drug therapy | Nanocomposites - administration & dosage | Antimitotic agents | Care and treatment | Antineoplastic agents | Health aspects | Plant metabolites | Cancer | Index Medicus | Cellular | Antiproliferatives | Metabolites | Biocompatibility | Plants (organisms) | Medical | Nanostructure | Conjugation
Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 23, pp. 6118 - 6129
Abstract Despite progress, combination therapy of different functional drugs to increase the efficiency of anticancer treatment still remains challenges. An... 
Advanced Basic Science | Dentistry | Chemotherapy | Controlled drug release | Nanoparticle | Polypeptide | Drug co-delivery | DIBLOCK COPOLYMERS | MATERIALS SCIENCE, BIOMATERIALS | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | NANOCARRIERS | MICELLES | COMBINATION | DOCETAXEL | NANOPARTICLES | THERAPY | METASTATIC BREAST-CANCER | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanocomposites - chemistry | Antineoplastic Combined Chemotherapy Protocols - chemistry | Nanocapsules - administration & dosage | Delayed-Action Preparations - chemistry | Lung Neoplasms - pathology | Male | Polyethylene Glycols - chemistry | Doxorubicin - chemistry | Nanocapsules - chemistry | Delayed-Action Preparations - administration & dosage | Pharmaceutical Vehicles - chemical synthesis | Paclitaxel - chemistry | Diffusion | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Peptides - chemistry | Treatment Outcome | Animals | Mice, Nude | Mice, Inbred BALB C | Carcinoma, Non-Small-Cell Lung - drug therapy | Nanocomposites - administration & dosage | Medical colleges | Ethylene glycol | Care and treatment | Anthracyclines | Fluorescence | Amino acids | Lung cancer, Non-small cell | Glutamate | Cobalt | Deoxycholic acid | Index Medicus | Nanoparticles | Drugs | Surgical implants | Therapy | Nanostructure | Doxorubicin | Tumors | Cancer
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 08/2014, Volume 136, Issue 33, pp. 11748 - 11756
All drugs for cancer therapy face several transportation barriers on their tortuous journey to the action sites. To overcome these barriers, an effective drug... 
GOLD NANOPARTICLES | THERAPEUTICS | STABILITY | IN-VIVO | NANOMEDICINE | RESISTANCE | SUPRAMOLECULAR NANOSTRUCTURES | NANOCAPSULES | COPOLYMER MICELLES | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | Prodrugs - administration & dosage | Small Molecule Libraries - pharmacology | Nanoparticles - chemistry | Apoptosis - drug effects | Small Molecule Libraries - administration & dosage | Drug Resistance, Multiple - drug effects | Humans | Prodrugs - chemistry | Chlorambucil - pharmacology | MCF-7 Cells | Mammary Neoplasms, Experimental - pathology | Molecular Structure | Iridium - chemistry | Mammary Neoplasms, Experimental - drug therapy | Chlorambucil - chemistry | Rats | Breast Neoplasms - drug therapy | Surface-Active Agents - pharmacology | Small Molecule Libraries - chemistry | Animals | Surface-Active Agents - administration & dosage | Breast Neoplasms - pathology | Mice, Nude | Organometallic Compounds - chemical synthesis | Organometallic Compounds - chemistry | Cell Proliferation - drug effects | Mice | Nanoparticles - administration & dosage | Surface-Active Agents - chemistry | Cell Cycle - drug effects | Surface-Active Agents - chemical synthesis | Drug Delivery Systems - methods | Prodrugs - pharmacology | Organometallic Compounds - pharmacology | Drug Resistance, Neoplasm - drug effects | Organometallic Compounds - administration & dosage | Drugs | Drug delivery systems | Care and treatment | Prodrugs | Dosage and administration | Research | Methods | Cancer | Vehicles | Index Medicus
Journal Article
Journal Article
Nanoscale, ISSN 2040-3364, 04/2015, Volume 7, Issue 13, pp. 5859 - 5868
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 06/2012, Volume 81, Issue 2, pp. 448 - 452
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 02/2014, Volume 86, Issue 2, pp. 167 - 177
Journal Article
ACS Applied Materials and Interfaces, ISSN 1944-8244, 05/2015, Volume 7, Issue 17, pp. 9235 - 9246
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 6/2013, Volume 47, Issue 3, pp. 1066 - 1080
Alzheimer’s disease (AD), a neurodegenerative disorder exhibiting a gradual decline in cognitive function, is characterized by the presence of neuritic plaques... 
Neurology | Neuroprotection | Neurosciences | Biomedicine | Alzheimer’s disease | Neurobiology | Resveratrol | Drug delivery | Amyloid-β peptide | Hippocampus | Cell Biology | Alzheimer's disease | NEURODEGENERATIVE DISORDERS | PROTEIN | DRUG-DELIVERY | ALZHEIMERS-DISEASE | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | INDOMETHACIN-LOADED NANOCAPSULES | NANOPARTICLES | PATHWAY | AMYLOID-BETA | Amyloid-beta peptide | TRANS-RESVERATROL | Neuroprotective Agents - therapeutic use | Stilbenes - adverse effects | Microglia - metabolism | Rats, Wistar | Stilbenes - therapeutic use | Astrocytes - pathology | Injections, Intraventricular | Glycogen Synthase Kinase 3 beta | JNK Mitogen-Activated Protein Kinases - metabolism | Male | Hippocampus - drug effects | Stilbenes - pharmacology | Synapses - pathology | Nanocapsules - chemistry | Lipids - chemistry | Neuroprotective Agents - pharmacology | Cytoprotection - drug effects | Microglia - pathology | Hippocampus - enzymology | Amyloid beta-Peptides - administration & dosage | Astrocytes - drug effects | Synapses - drug effects | Tissue Distribution - drug effects | Microglia - drug effects | Amyloid beta-Peptides - toxicity | Rats | Hippocampus - pathology | Enzyme Activation - drug effects | Glycogen Synthase Kinase 3 - metabolism | beta Catenin - metabolism | Animals | Memory Disorders - drug therapy | Signal Transduction - drug effects | Protein Stability - drug effects | Astrocytes - metabolism | Index Medicus
Journal Article